ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,500Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 663

$576K Total Retail Price of All Prescriptions

Rank: 46 out of 663

816 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
12% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 816 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

11% of this provider’s 816 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 11,918 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
SIMVASTATIN 964 905 1 1
LISINOPRIL 768 671 2 2
OMEPRAZOLE 733 635 3 4
ATENOLOL 546 528 4 10
AMLODIPINE BESYLATE 436 410 5 5
LEVOTHROID 397 340 10 6 19
METFORMIN HCL 348 319 7 9
HYDROCODONE-ACETAMINOPHEN 332 257 S3 8 6
TERAZOSIN HCL 314 305 9 38
FUROSEMIDE 300 290 10 7
LEVOTHYROXINE SODIUM 274 240 11 3
WARFARIN SODIUM 265 253 12 8
METOPROLOL TARTRATE 260 236 13 11
OXYCODONE-ACETAMINOPHEN 236 157 S2 14 26
LOSARTAN POTASSIUM 221 221 15 14
GLIPIZIDE 210 197 16 29
TAMSULOSIN HCL 182 175 17 24
LOVASTATIN 175 159 18 30
FLUTICASONE PROPIONATE 174 167 19 27
HYDROCHLOROTHIAZIDE 171 164 20 12
PROAIR HFA 167 133 21 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 158 156 22 22
ALENDRONATE SODIUM 157 140 23 15
TRAZODONE HCL 157 136 23 34
CITALOPRAM HBR 155 137 25 18
K-TAB 149 134 26 36
ALLOPURINOL 149 145 26 28
ATORVASTATIN CALCIUM 149 122 26 13
PRAVASTATIN SODIUM 143 125 29 21
FINASTERIDE 138 138 30 56
TRAMADOL HCL 130 119 31 17
GABAPENTIN 120 86 32 20
FLUOXETINE HCL 117 112 33 32
OXYCODONE HCL 113 66 S2 34 41
NORTRIPTYLINE HCL 111 93 35 63
TRIAMTERENE-HCTZ 107 96 36 42
RANITIDINE HCL 103 88 37 31
ZOLPIDEM TARTRATE 103 90 37 16
INSULIN SYRINGE 99 73 39 55
NOVOLIN N 98 78 40 44
PREDNISONE 94 87 41 39
TRIAMTERENE-HYDROCHLOROTHIAZID 93 93 42 49
ESTRADIOL 83 80 R 43 66
MORPHINE SULFATE ER 81 29 S2 44 51
DIGOXIN 78 75 45 50
PROPRANOLOL HCL 74 71 46 120
DILT-XR 72 67 47 100
AMOXICILLIN 65 56 48 234
SULFAMETHOXAZOLE-TRIMETHOPRIM 59 52 49 138
PANTOPRAZOLE SODIUM 58 44 50 45
NOVOLIN R 57 47 51 106
METOPROLOL SUCCINATE 54 51 52 25
SPIRIVA 54 54 52 62
QVAR 53 50 54 91
FENOFIBRATE 51 37 55 97
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 27, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.